| Autor: |
Ann C. Gaffey, MD, MS, Jason Zhang, MD, Major K. Lee, MD, PhD, Robert Roses, MD, Benjamin M. Jackson, MD, Jon G. Quatromoni, MD |
| Jazyk: |
angličtina |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Journal of Vascular Surgery Cases and Innovative Techniques, Vol 8, Iss 2, Pp 294-297 (2022) |
| Druh dokumentu: |
article |
| ISSN: |
2468-4287 |
| DOI: |
10.1016/j.jvscit.2022.04.001 |
| Popis: |
Improvements in chemoradiotherapy have rendered complex pancreatic cancers involving the portal vein (PV) amenable to resection. PV reconstruction (PVR) is an essential component. Various conduits have been proposed; however, the optimal choice remains unknown. Fourteen patients underwent PVR with a cadaveric descending thoracic aortic homograft from 2014 to 2020. The primary diagnosis was pancreatic cancer. The splenic vein was ligated in seven patients (50%). The 30-day and 3-, 12-, and 24-month primary patency rates were 100%, 86%, 76%, and 76%, respectively. We found a cadaveric descending thoracic aortic homograft is an excellent conduit for PVR, given the optimal size, rapidly availability, favorable risk profile, and absence of harvest site complications. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
